Sandoz Incorporated recalls Amitriptyline HCl Tablets, USP 25 mg, Packaged in a)100-count bottles (NDC 0781-1487-01) and b) 1000-count bottles ( ND…
- Recall date
- June 16, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0943-2017
- FDA classification
- Class III
- Brand / firm
- Sandoz Incorporated
- Sold / distributed
- Product was distributed throughout the United States
Why it was recalled
Cross Contamination With Other Product: Imipramine
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Amitriptyline HCl Tablets, USP 25 mg, Packaged in a)100-count bottles (NDC 0781-1487-01) and b) 1000-count bottles ( NDC 0781-1487-10), Rx only, Manufactured by Sandoz Inc., Princeton, NJ 08540
Get recall alerts
Free email alert whenever Sandoz Incorporated has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Sandoz Incorporated